CHARLES RIVER LABORATORIES HOLDINGS LIMITED
Get an alert when CHARLES RIVER LABORATORIES HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£0
Latest balance sheet
Net assets
£226M
-4.3% vs 2024
Employees
0
Average over period
Profit before tax
£6.9M
+205.9% highest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-27
| Metric | Trend | 2023-12-30 | 2024-12-28 | 2025-12-27 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £0 | £0 | £0 | — | |
| Operating profit | £10,702,000 | £6,453,000 | £6,207,000 | -3.8% | |
| Profit before tax | £2,873,000 | £2,254,000 | £6,895,000 | +205.9% | |
| Net profit | £2,873,000 | £2,254,000 | £6,762,000 | +200% | |
| Cash | £14,244,000 | £0 | £0 | — | |
| Total assets less current liabilities | £261,021,000 | £236,477,000 | £226,239,000 | -4.3% | |
| Net assets | £39,732,000 | £236,477,000 | £226,239,000 | -4.3% | |
| Equity | £39,732,000 | £236,477,000 | £226,239,000 | -4.3% | |
| Average employees | 0 | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-30 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|---|
| Return on capital employed | 4.1% | 2.7% | 2.7% | |
| Gearing (liabilities / total assets) | 84.8% | 0.0% | 0.0% | |
| Interest cover | 1.14x | 1.15x | 81.67x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Sumer Auditco Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis, which the directors believe to be appropriate given the strong net asset position at year end. The directors have prepared a cash flow forecast which shows that they expect the Company to be able to meet its operating obligations from available cash resources and the group's European cash pooling system as they fall due.”
Group structure
- CHARLES RIVER LABORATORIES HOLDINGS LIMITED · parent
- Charles River Laboratories Saint-Constant S.A. 100%
- Charles River UK Limited 100%
- Charles River Discovery Research Services U.K. Limited 100%
- Celsis Limited 100%
- KWS Biotest Limited 100%
- Biofocus DPI (Holdings) Limited 100%
- Celsis Group Limited 100%
- Celsis International Limited 100%
- Cobra Biologics Holdings Limited 100%
- Cobra Biologics Limited 100%
- Charles River Deteccao Microbiannae de Endotoxina Participacoes Ltd 100%
- Beijing Vital 100%
- Animal Technology Co., Ltd. 100%
- Hainan New Source Biotech Co., Ltd 100%
Significant events
- “On 24 February 2026, certain assets of Charles River Discovery Research Services UK Limited, the shares of which were 100% indirectly owned by the Company, were transferred to Charles River Laboratories England Limited, a newly incorporated company, the shares of which are 100% indirectly owned by the Company. On 25 February 2026 Charles River announced that it had entered into an agreement to divest certain assets of its Discovery and CDMO businesses, including the legal entity and a significant portion of the business of Charles River Discovery Research Services UK Limited. The divestiture was completed on 21 May 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HENEGHAN, Rushna | Secretary | 2021-01-01 | — | — |
| DUNN, Colin | Director | 2015-09-01 | Nov 1967 | British |
| HENEGHAN, Rushna | Director | 2021-01-01 | Jun 1963 | American |
| KNELL, Michael Gunnar | Director | 2025-09-29 | May 1976 | American |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANDREWS, Gary | Secretary | 2008-01-31 | 2019-12-22 |
| HAWKES, George Harold | Secretary | 1999-12-10 | 2000-12-31 |
| MEDHURST, Clive William | Secretary | 2001-01-01 | 2008-01-31 |
| PRICE, Sarah Margaret | Secretary | 2019-12-23 | 2020-12-31 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1999-12-10 | 1999-12-10 |
| ACKERMAN, Thomas Francis | Director | 2000-02-18 | 2015-08-31 |
| FOSTER, James C | Director | 2007-03-12 | 2015-08-31 |
| HAWKES, George Harold | Director | 1999-12-10 | 2000-12-31 |
| JOHST, David P | Director | 2007-03-12 | 2020-05-20 |
| PEASE, Flavia Houaiss | Director | 2022-06-06 | 2025-09-29 |
| PRICE, Sarah Margaret | Director | 2020-05-20 | 2020-12-31 |
| SHAUGHNESSY, Dennis Robert | Director | 1999-12-10 | 2005-04-25 |
| SMITH, Alan Roy | Director | 2000-02-18 | 2007-03-12 |
| SMITH, David Ross | Director | 2015-09-01 | 2022-06-06 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 1999-12-10 | 1999-12-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Charles River Nederland Bv | Corporate entity | Shares 75–100% | 2019-09-12 | Active |
Filing timeline
Last 20 of 121 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-01-23 RESOLUTIONS Resolution
- 2024-06-20 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-30 | AA | accounts | Accounts with accounts type full | |
| 2025-12-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-22 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2025-10-06 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-15 | AA | accounts | Accounts with accounts type full | |
| 2025-01-23 | RESOLUTIONS | resolution | Resolution | |
| 2025-01-22 | SH01 | capital | Capital allotment shares | |
| 2025-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-05 | AA | accounts | Accounts with accounts type full | |
| 2024-06-20 | RESOLUTIONS | resolution | Resolution | |
| 2024-06-17 | SH01 | capital | Capital allotment shares | |
| 2023-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-24 | AA | accounts | Accounts with accounts type full | |
| 2022-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-01 | AA | accounts | Accounts with accounts type full | |
| 2022-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-23 | TM01 | officers | Termination director company with name termination date | |
| 2022-01-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-22 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 1
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.